Basel, Switzerland

Fatma Limam

This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Novartis Technical Development Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fatma Limam. Retrieved from https://idiyas.com/inventor/fatma-limam-pq7rk1rc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Fatma Limam

Introduction

Fatma Limam is an accomplished inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative research and development efforts.

Latest Patents

Fatma Limam holds a patent for the invention titled "7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl) Compounds and Uses Thereof." This patent showcases her expertise in creating novel compounds that have potential applications in various therapeutic areas. She has a total of 1 patent to her name.

Career Highlights

Fatma is currently employed at Suzhou Novartis Technical Development Co., Ltd., where she continues to push the boundaries of pharmaceutical innovation. Her work is characterized by a commitment to improving healthcare outcomes through scientific advancements.

Collaborations

Throughout her career, Fatma has collaborated with notable colleagues, including Vincent Bordas and Jvan Brun. These partnerships have enriched her research and contributed to the success of her projects.

Conclusion

Fatma Limam exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and collaborative efforts highlight her dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…